Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders

Aging and Cognitive FunctionsAlzheimer’s DiseaseDementia

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

JAMA Neurol.

Mattsson N, Andreasson U, Zetterberg H, Blennow K; Alzheimer’s Disease Neuroimaging Initiative

doi: 10.1001/

RECOMMENDED

Alzheimer’s Disease

Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease

JAMA Neurol.

Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K

doi: 10.1001/jamaneurol.

Amyotrophic Lateral SclerosisDementia

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease

JAMA Neurol.

Gaiani A, Martinelli I, Bello L, Querin G, Puthenparampil M, Ruggero S, Toffanin E, Cagnin A, Briani C, Pegoraro E, Sorarù G

doi: 10.1001/jamaneurol.

Alzheimer’s Disease

FTIR Spectroscopy of Cerebrospinal Fluid Reveals Variations in the Lipid: Protein Ratio at Different Stages of Alzheimer's Disease

J Alzheimers Dis.

Depciuch J, Zawlik I, Skrzypa M, Pająk J, Potocka N, Łach K, Bartosik-Psujek H, Koziorowska A, Kaznowska E, Cebulski J

doi: 10.3233/JAD-

Aging and Cognitive Functions

REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease

Neurology.

Pagano G, De Micco R, Yousaf T, Wilson H, Chandra A, Politis M

doi: 10.1212/

Aging and Cognitive FunctionsAlzheimer’s DiseaseDementia

Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging

JAMA Neurol.

Mielke MM, Hagen CE, Wennberg AMV, Airey DC, Savica R, Knopman DS, Machulda MM, Roberts RO, Jack CR Jr, Petersen RC, Dage JL

doi: 10.1001/

Aging and Cognitive FunctionsAlzheimer’s Disease

Neutrophil activation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid

Ageing Res Rev.

Wu CY, Bawa KK, Ouk M, Leung N, Yu D, Lanctôt KL, Herrmann N, Pakosh M, Swardfager W

doi: 10.1016/j.arr.2020.101130.

Dementia

Serum Potassium Is Associated with Cognitive Decline in Patients with Lewy Body Dementia

doi: 10.3233/JAD-181131.

Aging and Cognitive FunctionsAlzheimer’s DiseaseDementia

Serum neurofilament light chain in behavioral variant frontotemporal dementia

Neurology.

Steinacker P, Anderl-Straub S, Diehl-Schmid J, Semler E, Uttner I, von Arnim CAF, Barthel H, Danek A, Fassbender K, Fliessbach K, Foerstl H, Grimmer T, Huppertz HJ, Jahn H, Kassubek J, Kornhuber J, Landwehrmeyer B, Lauer M, Maler JM, Mayer B, Oeckl P, Prudlo J, Schneider A, Volk AE, Wiltfang J, Schroeter ML, Ludolph AC, Otto M, FTLDc study group

doi: 10.1212/

Related content

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease

FTIR Spectroscopy of Cerebrospinal Fluid Reveals Variations in the Lipid: Protein Ratio at Different Stages of Alzheimer's Disease

REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease

Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging

Neutrophil activation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid

Serum Potassium Is Associated with Cognitive Decline in Patients with Lewy Body Dementia

Serum neurofilament light chain in behavioral variant frontotemporal dementia